CN101301434A - 一种治疗颈椎病的中药组合物 - Google Patents
一种治疗颈椎病的中药组合物 Download PDFInfo
- Publication number
- CN101301434A CN101301434A CNA2008101361961A CN200810136196A CN101301434A CN 101301434 A CN101301434 A CN 101301434A CN A2008101361961 A CNA2008101361961 A CN A2008101361961A CN 200810136196 A CN200810136196 A CN 200810136196A CN 101301434 A CN101301434 A CN 101301434A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- portions
- cervical spondylosis
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims description 50
- 208000029761 vertebral disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 56
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims abstract description 35
- 208000036319 cervical spondylosis Diseases 0.000 claims abstract description 34
- 208000005801 spondylosis Diseases 0.000 claims abstract description 34
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 15
- 241000545442 Radix Species 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 12
- 241000219780 Pueraria Species 0.000 claims description 6
- 241001180876 Saposhnikovia Species 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 241000244155 Taenia Species 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000008216 herbs Nutrition 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241001522129 Pinellia Species 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 24
- 230000036407 pain Effects 0.000 abstract description 22
- 208000002173 dizziness Diseases 0.000 abstract description 18
- 208000024891 symptom Diseases 0.000 abstract description 18
- 206010019233 Headaches Diseases 0.000 abstract description 14
- 231100000869 headache Toxicity 0.000 abstract description 14
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 208000005392 Spasm Diseases 0.000 abstract description 5
- 210000004204 blood vessel Anatomy 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 4
- 230000000916 dilatatory effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000003340 mental effect Effects 0.000 abstract description 3
- 206010016256 fatigue Diseases 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 201000010099 disease Diseases 0.000 description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 206010047700 Vomiting Diseases 0.000 description 10
- 210000003414 extremity Anatomy 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 239000009636 Huang Qi Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000000278 spinal cord Anatomy 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 206010033799 Paralysis Diseases 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 210000001364 upper extremity Anatomy 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000003387 muscular Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010005963 Bone formation increased Diseases 0.000 description 3
- 241000723353 Chrysanthemum Species 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000002161 motor neuron Anatomy 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 210000002385 vertebral artery Anatomy 0.000 description 3
- 206010009346 Clonus Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 206010017577 Gait disturbance Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028570 Myelopathy Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 241000522215 Dipteryx odorata Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000027768 Hoffmann sign Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 241000918585 Pythium aphanidermatum Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000863032 Trieres Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000004889 cervical nerve Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 206010029864 nystagmus Diseases 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 208000005198 spinal stenosis Diseases 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗颈椎病的中药组合物,各种成分的重量分数比为:防风10~20份,川芎10~20份,白芷10~20份,杜仲10~20份,羌活10~20份,葛根10~20份,丹参10~20份,当归10~20份,石决明10~20份,天麻10~20份,黄芪10~20份,桂枝10~20份,白芍10~20份。本发明治疗颈椎病的中药组合物可从根本上改善颈椎病患者的头痛、头晕、疲乏、失神等症状,通过扩张血管,健脾利胃,解除痉挛及镇痛、镇静等作用,使颈椎病患者的自觉症状得到明显的改善,精神状态好转。作为一种口服中药制剂,服用方便。
Description
技术领域
本发明涉及含有来源于植物原料的医用配制品,特别涉及一种治疗颈椎病的中药组合物。
背景技术
目前颈椎病的患病率已达14%。一旦患有该病,往往缠绵难愈,症状呈多元化,影响颈部神经根、血管、脊髓,出现头晕、头痛、颈肩背酸痛、上肢麻木、放射痛、下肢疲软无力等症状,特别是脊髓型颈椎病患者,轻则四肢痿废,重则发生瘫痪,不仅长期折磨患者本人,也给整个家庭、社会带来沉重的经济负担,是影响人们享有健康的重要障碍之一。该病已成为与现代社会相伴随的一种常见病和多发病,在整个脊柱病的发病谱中,颈椎病已上升为主要位置。
颈椎病或称颈椎骨关节炎、增生性颈椎炎、颈神经根综合症、颈椎间盘突出症等。本病系因颈椎长期劳损、骨质增生、椎间盘突出、韧带增厚,压迫颈脊髓、神经根和血液循环功能障碍导致的综合症。颈椎病是一种常见多发病,40岁以上的中老年人患病率高达90%。临床症状,当神经根受压迫时,表现为颈肩及上肢疼痛难忍,上肢肌力减退,肌肉萎缩;当脊髓受压迫时,如病变位于上颈段,可出现四肢上运动神经元性瘫痪,如病变位于下颈段,则上肢呈下运动神经元性瘫痪,下肢呈上运动神经元性瘫痪,严重者可伴有扩约肌功能障碍;当椎动脉受压迫时,表现为头晕、头痛、眩晕、昏厥、共济失调、步态不稳、视力模糊、眼球震颤、面部麻木、吞咽困难。以上症状根据颈椎病发病部位和轻重程度可单独出现或为混合型。西医对该病的治疗一般采用牵引、针灸,重症患者则采用手术治疗,给患者造成极大痛苦,而治疗效果却不尽人意。故该病属多年来中医主攻的顽症。
颈椎病病理基础是椎间盘的退行性变而引发的一系列病理改变(如:椎节失稳、松动、髓核突出或脱出,骨刺形成,韧带肥厚和继发的椎管狭窄等)刺激或压迫邻近的神经根脊髓以及椎动脉颈部交感神经等组织;再加上一些诱发因素(如:慢性劳损、急性外伤、发育性椎管狭窄以及脊柱的先天畸形和生理曲度改变等)而引起脊髓神经根的水肿,瘀血渗出等炎性反应,并逐渐纤维化甚至变性,产生以疼痛、麻木为主的临床症状。如果脊髓受压则产生一侧或双侧椎体束症状,如果累及椎动脉则引起椎动脉痉挛和血管狭窄,出现颅内供血不足的症状。中医没有统一的病因诊断分型标准。一般认为是外伤、风寒、湿邪侵袭、气血不和、经络不通、肝肾虚损等所致。将其分为:风寒湿痹型、气滞血瘀型、痰湿臃阻型、肝肾不足型等。治疗手段西医以手术、牵引为主,中医多以外用膏药,手法、推拿按摩、针炙为主,虽有效果,但不理想。
目前,中医治疗颈椎病的中药制剂较多,经临床使用证明,一些药疗效慢,疗程长,对病程较短、病情较轻的患者,疗效尚可,对病程较长,病情较重的患者,其疗效就不够明显。究其原因,因颈椎病患者多为中老年人,这个年龄段的人脾胃功能衰减,久病后脾胃消化吸收功能更差,有的病人面黄肌瘦,肌体自身抗病能力和对药物吸收能力很低,因此必须补充健胃利脾上用药才能达到扶正固本、提高疗效的作用。
发明内容
本发明所要解决的技术问题在于,提供一种可从根本上改善颈椎病患者的头痛、头晕、疲乏、失神的中药口服制剂。通过扩张血管,健脾利胃,解除痉挛及镇痛、镇静等作用,使颈椎病患者的自觉症状得到明显的改善,精神状态好转,且服用方便。
为解决上述技术问题,本发明提供了一种治疗颈椎病的中药组合物,各种成分的重量分数比为:防风10~20份,川芎10~20份,白芷10~20份,杜仲10~20份,羌活10~20份,葛根10~20份,丹参10~20份,当归10~20份,石决明10~20份,天麻10~20份,黄芪10~20份,桂枝10~20份,白芍10~20份。
所述的治疗颈椎病的中药组合物,各种成分的重量分数比可以为:防风10~15份,川芎10~15份,白芷10~15份,杜仲10~15份,羌活10~15份,葛根10~15份,丹参10~15份,当归15~20份,石决明15~20份,天麻15~20份,黄芪15~20份,桂枝15~20份,白芍15~20份。
治疗颈椎病的中药组合物各种成分的重量分数比还可以为:防风15~20份,川芎15~20份,白芷15~20份,杜仲10~15份,羌活10~20份,葛根15~20份,丹参15~20份,当归15~20份,石决明15~20份,天麻10~15份,黄芪10~15份,桂枝10~15份,白芍10~15份。
所述组合物可以进一步包括按照重量分数比的以下成分:竹茹10~15份,半夏10~15份。
所述组合物还可以进一步包括按照重量分数比的以下成分:草决明10~15份,杭白菊10~15份。
所述组合药物剂型可以为草药汤剂、散剂、蜜炼丸剂、水合丸剂,片剂、胶囊、口服液、颗粒剂、胶剂或糖浆剂。
所述中药组合物散剂的制备方法包括:
粉碎的步骤:将所述原料按配比混合,投入粉碎机粉碎成细粉,粒度为80~120目;
混合的步骤:将上述步骤所得细粉投入混合搅拌机充分混匀;
包装的步骤:将混匀后的细粉用小瓶或包装盒分装,每5~10克为一袋或一盒分装。
所述中药组合物的给药方式为口服。
本发明的优点在于,原料均为中药,无毒副作用,不留后遗症;本发明中药组合物可以为多种剂型,服用方便;本发明中药组合物制作方法简单,所需设备少,操作容易;本发明中药组合物疗效好,见效快,标本兼治,患者无不良反应。
具体实施方式
本发明治疗颈椎病的中药组合物可从根本上改善颈椎病患者的头痛、头晕、疲乏、失神等症状,通过扩张血管,健脾利胃,解除痉挛及镇痛、镇静等作用,使颈椎病患者的自觉症状得到明显的改善,精神状态好转。
其中各药药性如下:
防风:解表祛风,胜湿,止痉。
川芎:行气开郁,法风燥湿,活血止痛,治风冷头痛旋晕,胁痛腹疼,寒痹筋挛,经闭,难产,产后瘀阻块痛,痈疽疮疡。用于月经不调,经闭痛经,瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
白芷:祛风散寒,通窍止痛,消肿排脓,燥湿止带。有解热、镇痛、抗严作用。小量白芷毒素有兴奋延髓血管运动中枢、呼吸中枢、迷走神经及脊髓的作用;能升高血压,使脉搏变慢、呼吸加深,引起流涎呕吐,大剂量可引起痉挛继而麻痹。所含呋喃香豆类化合物有光敏性作用,对平滑肌有解痉作用。
杜仲:治腰脊酸疼,肢体痿弱,遗精,滑精,五更泄泻,虚劳,小便余沥,阴下湿痒。王好古:“肝经气分。”《雷公炮制药性解》:“入肾经。”《本草经解》:“入手太阴肺经。”牛膝补肝肾,强筋骨,逐瘀通经,引血下行。用于腰膝酸痛,筋骨无力,经闭症瘕,肝阳眩晕。
羌活:散寒解表,祛风湿,止痛。辛温,气雄而散,发表力强,主散太阳经风邪及寒湿之邪,有散寒祛风、胜湿止痛之功,故善治风寒湿邪龙表,恶寒发热、肌表无汗、头痛项强、肢体酸痛者。
葛根:解表退热,生津,透疹,升阳止泻。用于外感发热头痛、高血压颈项强痛、口渴、消渴、麻疹不透、热痢、泄泻。《本草纲目》载:葛根,性凉、气平、味甘,具清热、降火、排毒诸功效。现代医学研究表明:葛根中的异黄酮类化合物葛根素对高血压、高血脂、高血糖和心脑血管疾病有一定疗效。
丹参:丹参能够促进组织的修复与再生,丹参能够促进纤维母细胞分化、胶原纤维形成较明显;肉芽形成比较成熟。局部淤血减轻、血液循环改善,愈合时间缩短。抑制过度增生对过度增生的纤维母细胞有抑制作用。
当归:补血活血,调经止痛,润肠通便。莪术破血行气止痛,温通力较大,可治疗血滞经闭腹痛、腹部包块、积聚,消积散结,行气消积止痛,破血祛瘀,行气止痛。
石决明:平肝熄风,潜阳,除热明目。主肝阳上亢、头目眩晕、虚劳骨蒸、吐血、青盲内障等症。
天麻:平肝息风止痉。用于头痛眩晕,肢体麻木,手足不遂,小儿惊风,癫痫抽搐,破伤风。
黄芪:补气升阳,托疮生肌;用于温养脾胃而生肌,用于气血不足,疮疡内陷,久溃不敛;健脾益气,且有调节机体的免疫功能。
桂枝:发汗解表,温经止痛,助阳化气。
白芍:白芍养血柔肝,缓中止痛,敛阴收汗。《本经》:″主邪气腹痛,除血痹,破坚积,治寒热疝瘕,止痛,利小便,益气。″《别录》:″通顺血脉,缓中,散恶血,逐贼血,去水气,利膀胱、大小肠,消痈肿,(治)时行寒热,中恶腹痛,腰痛。″《药性论》:″治肺邪气,腹中疞痛,血气积聚,通宣脏腑拥气,治邪痛败血,主时疾骨热,强五脏,补肾气,治心腹坚胀,妇人血闭不通,消瘀血,能蚀脓。″
患者如有恶心呕吐等症状,在本发明中药组合物中加入以下两味药:
竹茹:清热化痰,除烦止呕。用于痰热咳嗽,胆火挟痰,烦热呕吐,惊悸失眼,中风痰迷,舌强不语,胃热呕吐,妊娠恶阻,胎动不安。
半夏:辛散温燥有毒,主入脾胃兼入肺,能行水湿,降逆气,而善祛脾胃湿痰。水湿去则脾健而痰涎自消,逆气降则胃和而痞满呕吐自止,故为燥湿化痰,降逆止呕,消痞散结之良药。既主治脾湿痰壅之痰多咳喘气逆,又治湿痰上犯之眩晕心悸失眠,还可治风痰吐逆,头痛肢麻,半身不遂,口眼歪斜等症。可治疗其他原因所致的呕恶,善治胃气上逆之恶心呕吐,痰湿中阻之胸脘痞闷,气郁痰结咽中如有物阻之梅核气,若痰热互结之心下痞,还可治痰湿凝滞经络或肌肉所致的瘿瘤痰核及痈疽肿毒。
患者如有目赤头晕等症状,在本发明中药组合物中加入以下两味药:
草决明:清热明目,润肠通便。用于目赤涩痛、羞明多泪、头痛眩晕、目暗不明、润肠通便。此外草决明还有降低血清胆固醇与降血压的功效,防治血管硬化与高血压有一定疗效。
杭白菊:经现代医学验证,菊中含有有效化学成分,如腺嘌呤、胆碱、水苏碱等,从菊中提炼出来的挥发油,含有菊花酮、龙脑、乙酸龙脑酯等。药理实验证明,白菊煎剂对宋氏痢疾杆菌、变形杆菌、伤寒杆菌、副伤寒杆菌、绿脓杆菌、大肠杆菌及霍乱弧菌等都有抑制作用。《本草正》:″善利水,捣汁和酒服之,大治癃闭。″《纲目拾遗》:″治疔肿,喉疔,喉癣。″
具体实施例1:赵女士,33岁。颈肩疼痛3年,伴左半身麻木,右手无力,持物不稳,行走困难。检查:颈后疼痛,颈椎压痛,颈活动受限,行走困难,便溏溲多,夜寐失宁,咽喉疼痛。苔薄腻,脉沉细。用以下药方:
防风10g,川芎10g,白芷10g,杜仲10g,羌活10g,葛根10g,丹参10g,当归10g,石决明10g,天麻10g,黄芪10g,桂枝10g,白芍10g。
一日一次,十日后,体松肢轻,右手麻木减少。再服二十日后,诸症状均见缓解。一年后随访病症缓解。
具体实施例2:萧先生,52岁。颈项板滞不舒,头晕、头痛、头重已7年。颈项板滞不舒始于5年前,并有肩背牵制不适感。头重头晕,眩晕,泛恶,头重如蒙裹一般,四肢乏力,呆纳失寐。检查颈椎骨质增生,苔白腻,脉细涩。
用以下药方:防风15g,川芎15g,白芷10g,杜仲10g,羌活10g,葛根10g,丹参15g,当归15g,石决明15g,天麻15g,黄芪15g,桂枝15g,白芍15g。
一日一次,服用十日后诸恙已减轻,泛恶呕吐已愈,头痛头重已解,唯有轻度头晕,患者精神亦较前有明显改善。再服两个月诸症消失。半年后随访,未复发。
具体实施例3:王先生,56岁,患颈椎病4年,双手麻木,肩臂疼痛,头晕目眩,属颈动脉型颈椎病,经多种药物治疗均不见好转。
用以下药方:防风15g,川芎15g,白芷15g,杜仲10g,羌活10g,葛根15g,丹参15g,当归15g,石决明15g,天麻10g,黄芪10g,桂枝10g,白芍10g。
服用本药一周,症状明显好转,继续服用半年,痊愈,随访两年无复发。
具体实施例4:张小姐,28岁,颈椎痛伴肩部肢麻木一月,头晕,双上肢麻木,肌力减退,双乳下躯体感觉消失,双下肢无力,如踏棉花感,不能直立行走,大小便正常,经常恶心呕吐。检查:四肢肌张力增强,双膝反射亢进,霍夫曼征阳性。曾住院治疗效果不明显。
用以下药方:防风20g,川芎20g,白芷20g,杜仲15g,羌活20g,葛根20g,丹参20g,当归20g,石决明20g,天麻15g,黄芪15g,桂枝15g,白芍15g,竹茹15g,半夏15g。
改用本发明的中药组合物,治疗一月,基本痊愈,又巩固治疗两个月完全康复,随访至今很好。
具体实施例5:楚先生,38岁,早晨醒来,突然发现左侧耳聋,三天后出现房屋旋转,但无耳鸣。后又出现走路不稳,双脚发硬,有时猝倒。检查:四肢肌张力高,颈椎平片C 5、6、7椎间空狭窄,C 5、6、7后缘骨质增生,诊断为脊髓型颈椎病。服用“颈复康”效果不明显。
用以下药方:防风15g,川芎15g,白芷15g,杜仲10g,羌活10g,葛根15g,丹参15g,当归15g,石决明15g,天麻10g,黄芪10g,桂枝10g,白芍10g,草决明10g,杭白菊10g。
改用本发明的中药组合物一个月,各种症状明显改善,两个月后症状消失,能独自骑自行车上街,恢复正常工作。
本发明治疗颈椎病的中药组合物,剂型可以为草药汤剂、散剂、蜜炼丸剂、水合丸剂,片剂、胶囊、口服液、颗粒剂、胶剂或糖浆剂。
本发明中药组合物散剂的制备方法包括:
粉碎的步骤:将所述原料按配比混合,投入粉碎机粉碎成细粉,粒度为80~120目;
混合的步骤:将上述步骤所得细粉投入混合搅拌机充分混匀;
包装的步骤:将混匀后的细粉用小瓶或包装盒分装,每5~10克为一袋或一盒分装。
本发明中药组合物的给药方式为口服。
本发明治疗颈椎病的中药组合物在临床上经过2年的试用,疗效良好,参加试用者共230人,年龄最大的68岁,最小的22岁。其中女性占52%,男性占48%,服药时间最长6个月,最短的30天,本发明中药组合物疗效显著,总有效率达93%。
Claims (8)
1.一种治疗颈椎病的中药组合物,其特征在于,各种成分的重量分数比为:防风10~20份,川芎10~20份,白芷10~20份,杜仲10~20份,羌活10~20份,葛根10~20份,丹参10~20份,当归10~20份,石决明10~20份,天麻10~20份,黄芪10~20份,桂枝10~20份,白芍10~20份。
2.根据权利要求1所述的治疗颈椎病的中药组合物,其特征在于,各种成分的重量分数比为:防风10~15份,川芎10~15份,白芷10~15份,杜仲10~15份,羌活10~15份,葛根10~15份,丹参10~15份,当归15~20份,石决明15~20份,天麻15~20份,黄芪15~20份,桂枝15~20份,白芍15~20份。
3.根据权利要求1所述的治疗颈椎病的中药组合物,其特征在于,各种成分的重量分数比为:防风15~20份,川芎15~20份,白芷15~20份,杜仲10~15份,羌活10~20份,葛根15~20份,丹参15~20份,当归15~20份,石决明15~20份,天麻10~15份,黄芪10~15份,桂枝10~15份,白芍10~15份。
4.根据权利要求1所述的治疗颈椎病的中药组合物,其特征在于,所述组合物进一步包括按照重量分数比的以下成分:竹茹10~15份,半夏10~15份。
5.根据权利要求1所述的治疗颈椎病的中药组合物,其特征在于,所述组合物进一步包括按照重量分数比的以下成分:草决明10~15份,杭白菊10~15份。
6.根据权利要求1~5中任一项所述的治疗颈椎病的中药组合物,其特征在于,所述组合药物剂型为草药汤剂、散剂、蜜炼丸剂、水合丸剂,片剂、胶囊、口服液、颗粒剂、胶剂或糖浆剂。
7.根据权利要求1~5中任一项所述治疗颈椎病的中药组合物,其特征在于,所述中药组合物散剂的制备方法包括:
粉碎的步骤:将所述原料按配比混合,投入粉碎机粉碎成细粉,粒度为80~120目;
混合的步骤:将上述步骤所得细粉投入混合搅拌机充分混匀;
包装的步骤:将混匀后的细粉用小瓶或包装盒分装,每5~10克为一袋或一盒分装。
8.根据权利要求1~5中任一项所述治疗颈椎病的中药组合物,其特征在于,所述中药组合物的给药方式为口服。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101361961A CN101301434B (zh) | 2008-07-10 | 2008-07-10 | 一种治疗颈椎病的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101361961A CN101301434B (zh) | 2008-07-10 | 2008-07-10 | 一种治疗颈椎病的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101301434A true CN101301434A (zh) | 2008-11-12 |
CN101301434B CN101301434B (zh) | 2012-01-11 |
Family
ID=40111651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101361961A Expired - Fee Related CN101301434B (zh) | 2008-07-10 | 2008-07-10 | 一种治疗颈椎病的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101301434B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966331A (zh) * | 2010-10-22 | 2011-02-09 | 江苏省中医院 | 一种治疗颈椎病的药物及其制备方法 |
CN102671127A (zh) * | 2012-05-17 | 2012-09-19 | 浙江省新华医院 | 用于治疗颈椎病的中药制剂 |
CN102743703A (zh) * | 2012-07-18 | 2012-10-24 | 山东益宝生物制品有限公司 | 一种治疗颈椎病的药物及其制备方法 |
CN102846976A (zh) * | 2012-09-28 | 2013-01-02 | 郑州中医骨伤病医院 | 治疗颈椎病的颈痛康复丸 |
CN103055165A (zh) * | 2012-12-28 | 2013-04-24 | 青岛爱维互动信息技术有限公司 | 一种治疗颈椎病的药物 |
CN103393868A (zh) * | 2013-07-24 | 2013-11-20 | 张健 | 颈椎康复冲剂 |
CN103610831A (zh) * | 2013-11-15 | 2014-03-05 | 李沂红 | 一种治疗颈肩痛的中药 |
CN104547633A (zh) * | 2014-12-25 | 2015-04-29 | 四川天联药业有限公司 | 一种治疗颈椎病的中药组合物及其制备方法 |
CN104922483A (zh) * | 2015-06-12 | 2015-09-23 | 公安县中医医院 | 一种治疗颈椎病的颗粒剂 |
CN106138780A (zh) * | 2016-08-30 | 2016-11-23 | 佘延英 | 用于治疗颈椎病的中药组合物 |
CN107551259A (zh) * | 2017-09-29 | 2018-01-09 | 南京仙草堂生物科技有限公司 | 一种含有蝎毒素的颈椎病治疗喷剂的制备方法 |
CN107551260A (zh) * | 2017-09-29 | 2018-01-09 | 南京仙草堂生物科技有限公司 | 一种含有蝎毒素的颈椎病治疗喷剂 |
CN108465059A (zh) * | 2018-06-25 | 2018-08-31 | 深圳市中医院 | 治疗风寒痹阻和气滞血瘀型颈椎病的中药组合物、中药制剂及丸剂的制备方法 |
CN112353890A (zh) * | 2020-11-24 | 2021-02-12 | 赵子荣 | 一种用于治疗颈椎和腰椎间盘突出病的中药 |
CN114377092A (zh) * | 2022-01-18 | 2022-04-22 | 云南省中医医院(云南中医药大学第一附属医院) | 一种治疗风寒阻络神经根型颈椎病的中药组合物、制剂与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1277575C (zh) * | 2002-09-23 | 2006-10-04 | 徐延青 | 一种治疗骨质增生的药物及其制备方法 |
CN101194990B (zh) * | 2007-03-16 | 2010-10-13 | 张桐亮 | 一种治疗颈肩腰腿痛的中药膏剂 |
CN101085304B (zh) * | 2007-06-18 | 2010-06-02 | 付先进 | 一种主要治疗颈腰椎疾病的膏药 |
-
2008
- 2008-07-10 CN CN2008101361961A patent/CN101301434B/zh not_active Expired - Fee Related
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966331B (zh) * | 2010-10-22 | 2012-03-14 | 江苏省中医院 | 一种治疗颈椎病的药物及其制备方法 |
CN101966331A (zh) * | 2010-10-22 | 2011-02-09 | 江苏省中医院 | 一种治疗颈椎病的药物及其制备方法 |
CN102671127A (zh) * | 2012-05-17 | 2012-09-19 | 浙江省新华医院 | 用于治疗颈椎病的中药制剂 |
CN102743703A (zh) * | 2012-07-18 | 2012-10-24 | 山东益宝生物制品有限公司 | 一种治疗颈椎病的药物及其制备方法 |
CN102743703B (zh) * | 2012-07-18 | 2013-12-18 | 山东益宝生物制品有限公司 | 一种治疗颈椎病的药物及其制备方法 |
CN102846976A (zh) * | 2012-09-28 | 2013-01-02 | 郑州中医骨伤病医院 | 治疗颈椎病的颈痛康复丸 |
CN103055165A (zh) * | 2012-12-28 | 2013-04-24 | 青岛爱维互动信息技术有限公司 | 一种治疗颈椎病的药物 |
CN103393868A (zh) * | 2013-07-24 | 2013-11-20 | 张健 | 颈椎康复冲剂 |
CN103610831A (zh) * | 2013-11-15 | 2014-03-05 | 李沂红 | 一种治疗颈肩痛的中药 |
CN104547633B (zh) * | 2014-12-25 | 2018-01-23 | 四川德峰药业有限公司 | 一种治疗颈椎病的中药组合物及其制备方法 |
CN104547633A (zh) * | 2014-12-25 | 2015-04-29 | 四川天联药业有限公司 | 一种治疗颈椎病的中药组合物及其制备方法 |
CN104922483A (zh) * | 2015-06-12 | 2015-09-23 | 公安县中医医院 | 一种治疗颈椎病的颗粒剂 |
CN104922483B (zh) * | 2015-06-12 | 2018-03-27 | 公安县中医医院 | 一种治疗颈椎病的颗粒剂 |
CN106138780A (zh) * | 2016-08-30 | 2016-11-23 | 佘延英 | 用于治疗颈椎病的中药组合物 |
CN107551259A (zh) * | 2017-09-29 | 2018-01-09 | 南京仙草堂生物科技有限公司 | 一种含有蝎毒素的颈椎病治疗喷剂的制备方法 |
CN107551260A (zh) * | 2017-09-29 | 2018-01-09 | 南京仙草堂生物科技有限公司 | 一种含有蝎毒素的颈椎病治疗喷剂 |
CN108465059A (zh) * | 2018-06-25 | 2018-08-31 | 深圳市中医院 | 治疗风寒痹阻和气滞血瘀型颈椎病的中药组合物、中药制剂及丸剂的制备方法 |
CN112353890A (zh) * | 2020-11-24 | 2021-02-12 | 赵子荣 | 一种用于治疗颈椎和腰椎间盘突出病的中药 |
CN114377092A (zh) * | 2022-01-18 | 2022-04-22 | 云南省中医医院(云南中医药大学第一附属医院) | 一种治疗风寒阻络神经根型颈椎病的中药组合物、制剂与应用 |
CN114377092B (zh) * | 2022-01-18 | 2023-01-31 | 云南省中医医院(云南中医药大学第一附属医院) | 一种治疗风寒阻络神经根型颈椎病的中药组合物、制剂与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101301434B (zh) | 2012-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101301434B (zh) | 一种治疗颈椎病的中药组合物 | |
CN107095982A (zh) | 一种熥敷药剂及其制备方法 | |
CN101905011A (zh) | 一种用于治疗颈椎病的中药组合物 | |
CN103599404A (zh) | 一种治疗颈椎病的中药汤剂 | |
CN101406668B (zh) | 一种治疗头痛头晕的中药组合物及其制备方法 | |
CN106520487A (zh) | 一种有助于睡眠的保健酒及其制备方法 | |
CN102935185B (zh) | 一种用于治疗神经衰弱的丸剂及制备方法 | |
CN104825956A (zh) | 防治中风、康复筋骨关节的药 | |
CN104173776A (zh) | 治疗颈椎病变性头痛的药物制剂及制备方法 | |
CN1977934A (zh) | 一种治疗颈椎病、腰椎间盘突出症的药酒及制备方法 | |
CN103920058A (zh) | 一种治疗头痛的中药制剂及其制备方法 | |
CN100496542C (zh) | 一种治疗痹证型颈椎病的中药复方制剂及制备方法 | |
CN103202964B (zh) | 益脑安神药酒 | |
CN103142897B (zh) | 一种贲门失弛缓症术后用药 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN104491734A (zh) | 一种治疗颈椎病的郁元芷麻丸中药 | |
CN104740481A (zh) | 一种治疗功能性子宫出血的中药 | |
CN112915148A (zh) | 一种治疗阳痿、早泄及性功能障碍的中药组合物 | |
CN104225128A (zh) | 缓解颈椎病所致头痛的药物制剂及制备方法 | |
CN103142898B (zh) | 一种贲门失弛缓症术后用药的制备方法 | |
CN102423422A (zh) | 用于治疗颈椎综合症的中药组合物 | |
CN106728975A (zh) | 一种治疗风寒痹阻型神经根型颈椎病的中药组合物 | |
CN104784588A (zh) | 一种用于治疗神经性头痛的中药制剂及制备方法 | |
CN106214965A (zh) | 一种可有效治疗颈椎病的汤剂药物及其制备方法 | |
CN104083588A (zh) | 腰肌劳损合并肿硬症状骨科药酒及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120111 Termination date: 20120710 |